检索结果 - Shi-Yong Sun

Refine Results
  1. 1
    mTOR kinase inhibitors as potential cancer therapeutic drugs

    mTOR kinase inhibitors as potential cancer therapeutic drugs 由 Shi‐Yong Sun

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    N-acetylcysteine, reactive oxygen species and beyond

    N-acetylcysteine, reactive oxygen species and beyond 由 Shi‐Yong Sun

    出版 2010
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  3. 3
    mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?

    mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why? 由 Shi‐Yong Sun

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Modulation of death receptors by cancer therapeutic agents

    Modulation of death receptors by cancer therapeutic agents 由 Heath A. Elrod, Shi‐Yong Sun

    出版 2008
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    PPAR<i>γ</i> and Apoptosis in Cancer

    PPAR<i>γ</i> and Apoptosis in Cancer 由 Heath A. Elrod, Shi‐Yong Sun

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling

    Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling 由 You-Take Oh, Shi‐Yong Sun

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Apoptosis as a Novel Target for Cancer Chemoprevention

    Apoptosis as a Novel Target for Cancer Chemoprevention 由 Shi‐Yong Sun, Numsen Hail, Reuben Lotan

    出版 2004
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Gene expression profiling of Non-small cell lung cancer

    Gene expression profiling of Non-small cell lung cancer 由 Sunil Singhal, Daniel Miller, Suresh S. Ramalingam, Shi‐Yong Sun

    出版 2008
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

    MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer 由 Qiming Wang, Sen Yang, Kai Wang, Shi‐Yong Sun

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer

    Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer 由 Chen Wu, Danlei Yu, Shi‐Yong Sun, Feng Li

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation

    Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation 由 Wei Zou, Ping Yue, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    The eIF4E/eIF4G Interaction Inhibitor 4EGI-1 Augments TRAIL-Mediated Apoptosis through c-FLIP Down-regulation and DR5 Induction Independent of Inhibition of Cap-Dependent Protein Translation

    The eIF4E/eIF4G Interaction Inhibitor 4EGI-1 Augments TRAIL-Mediated Apoptosis through c-FLIP Down-regulation and DR5 Induction Independent of Inhibition of Cap-Dependent Protein T... 由 Songqing Fan, Yikun Li, Ping Yue, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation

    mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation 由 Junghui Koo, Ping Yue, Xingming Deng, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Evidence That Retinoic Acid Receptor β Induction by Retinoids Is Important for Tumor Cell Growth Inhibition

    Evidence That Retinoic Acid Receptor β Induction by Retinoids Is Important for Tumor Cell Growth Inhibition 由 Shi‐Yong Sun, Haisu Wan, Ping Yue, Waun Ki Hong, Reuben Lotan

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation

    Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation 由 Junghui Koo, Xiaoyun Wu, Zixu Mao, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth

    Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth 由 Junghui Koo, Ping Yue, Anthony A. Gal, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Cellular FLICE-Inhibitory Protein Down-regulation Contributes to Celecoxib-Induced Apoptosis in Human Lung Cancer Cells

    Cellular FLICE-Inhibitory Protein Down-regulation Contributes to Celecoxib-Induced Apoptosis in Human Lung Cancer Cells 由 Liu X, Ping Yue, Axel H. Schönthal, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells

    Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells 由 Liu X, P Yue, Zhi‐Yuan Zhou, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues

    Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues 由 Songqing Fan, Suresh S. Ramalingam, John Kauh, Zhiheng Xu, Fadlo R. Khuri, Shi‐Yong Sun

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib

    ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib 由 Yiting Li, Hongjing Zang, Guoqing Qian, Taofeek K. Owonikoko, Suresh S. Ramalingam, Shi‐Yong Sun

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: